Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gutmann

Showing results (31-40 of 434) with videos related to

Pageof 44
Sort By:
Cell Cycle (Georgetown, Tex.)|January 5, 2012
Deconvoluting mTOR biologyJason D Weber, David H Gutmann
Nature Reviews. Clinical Oncology|August 14, 2013
Advances in the treatment of neurofibromatosis-associated tumoursAndrew L Lin, David H Gutmann
Expert Review of Anticancer Therapy|February 6, 2015
Improving outcomes for neurofibromatosis 1-associated brain tumorsNicole M Brossier, David H Gutmann
Neurologic Clinics|November 16, 2002
Neurofibromatosis 1Timothy M Lynch, David H Gutmann
Cancer Cell|May 10, 2017
Using Epigenetic Reprogramming to Treat Pediatric Brain CancerMilan G Chheda, David H Gutmann
Cancer Research|March 16, 2002
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosisRosalie E Ferner, David H Gutmann
Handbook of Clinical Neurology|November 14, 2015
Neurofibromatosis type 1Jacqueline L Anderson, David H Gutmann
Journal of Child Neurology|December 17, 2017
Optic Pathway Gliomas in Neurofibromatosis Type 1Cynthia J Campen, David H Gutmann
Expert Review of Neurotherapeutics|April 7, 2009
Gliomas in patients with neurofibromatosis type 1Anne C Albers, David H Gutmann
Human Molecular Genetics|April 3, 2007
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growthGirish C Daginakatte, David H Gutmann
Pageof 44

Showing results (31-40 of 434) with videos related to

Sort By:
Pageof 44
Cell Cycle (Georgetown, Tex.)|January 5, 2012
Deconvoluting mTOR biologyJason D Weber, David H Gutmann
Nature Reviews. Clinical Oncology|August 14, 2013
Advances in the treatment of neurofibromatosis-associated tumoursAndrew L Lin, David H Gutmann
Expert Review of Anticancer Therapy|February 6, 2015
Improving outcomes for neurofibromatosis 1-associated brain tumorsNicole M Brossier, David H Gutmann
Neurologic Clinics|November 16, 2002
Neurofibromatosis 1Timothy M Lynch, David H Gutmann
Cancer Cell|May 10, 2017
Using Epigenetic Reprogramming to Treat Pediatric Brain CancerMilan G Chheda, David H Gutmann
Cancer Research|March 16, 2002
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosisRosalie E Ferner, David H Gutmann
Handbook of Clinical Neurology|November 14, 2015
Neurofibromatosis type 1Jacqueline L Anderson, David H Gutmann
Journal of Child Neurology|December 17, 2017
Optic Pathway Gliomas in Neurofibromatosis Type 1Cynthia J Campen, David H Gutmann
Expert Review of Neurotherapeutics|April 7, 2009
Gliomas in patients with neurofibromatosis type 1Anne C Albers, David H Gutmann
Human Molecular Genetics|April 3, 2007
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growthGirish C Daginakatte, David H Gutmann
Pageof 44